Cargando…
Therapeutic Antibodies against Intracellular Tumor Antigens
Monoclonal antibodies are among the most clinically effective drugs used to treat cancer. However, their target repertoire is limited as there are relatively few tumor-specific or tumor-associated cell surface or soluble antigens. Intracellular molecules represent nearly half of the human proteome a...
Autores principales: | Trenevska, Iva, Li, Demin, Banham, Alison H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563323/ https://www.ncbi.nlm.nih.gov/pubmed/28868054 http://dx.doi.org/10.3389/fimmu.2017.01001 |
Ejemplares similares
-
Comprehensive mutagenesis identifies the peptide repertoire of a p53 T-cell receptor mimic antibody that displays no toxicity in mice transgenic for human HLA-A*0201
por: Trenevska, Iva, et al.
Publicado: (2021) -
Opportunities and Challenges for Antibodies against Intracellular Antigens
por: Yang, Xiaofeng, et al.
Publicado: (2019) -
The Notch Ligand Jagged1 as a Target for Anti-Tumor Therapy
por: Li, Demin, et al.
Publicado: (2014) -
Protective Effect of Vaccine Promoted Neutralizing Antibodies against the Intracellular Pathogen Chlamydia trachomatis
por: Olsen, Anja Weinreich, et al.
Publicado: (2017) -
Intracellular Salmonella delivery of an exogenous immunization antigen refocuses CD8 T cells against cancer cells, eliminates pancreatic tumors and forms antitumor immunity
por: Raman, Vishnu, et al.
Publicado: (2023)